Biden EO Places More Controls on Chinese Genomics Companies

Biden EO Places More Controls on Chinese Genomics Companies

Published On: 03/01/2024Tags: 340B, Agencies, Biopharma, Cell and Gene Therapy, Clinical Labs, Dialysis/ESRD, Health Insurance, Hospitals, Oncology, PBMs, Physicians, Post Acute Care, Value-Based Care

Access Memo Here